Evidence Library

Showing 10 of 117 results.

Prescription drug monitoring programs (PDMPs) collect patient-specific prescription information in centralized databases in an effort to reduce the misuse of controlled medicines. This dataset encompasses laws regulating which professions have access to the database and for what purpose, whether practitioners can delegate their access, whether patients can see their own information, and the extent to which access to individually-identified records may be granted for law enforcement purposes.

This is a longitudinal dataset, displaying laws from January 1, 1998 to July 1, 2016.

 

According to the CDC, 91 Americans die from opioid overdoses every day, and prescriptions for opioids are involved in almost half of all opioid overdose deaths. Some states have adopted laws that designate certain medical practices that provide management services as pain management clinics and subject these clinics to extra regulation. This dataset focuses on state laws that regulate pain management clinics, clinic owners, and the physicians that work at the clinics.

This dataset is longitudinal, capturing laws from January 1, 2006 through June 1, 2018.

 

According to the CDC, since 1999 the number of opioid prescriptions have quadrupled. With a significant amount of those opioid prescriptions being written for acute pain or in emergency departments, some states have developed opioid prescribing guidelines for acute and emergency care to help avoid over prescribing. These guidelines are generally adopted by statutes, regulations, state department guidelines, and medical board guidelines.

 

As more states have continued to pass laws legalizing medical use of marijuana, the majority have also established product safety measures to protect consumers. These safety regulations vary from state to state. This dataset analyzes state guidelines for medical marijuana product preparation, testing, packaging, labeling, and advertising, all factors that contribute to overall product safety. This dataset includes states with comprehensive medical marijuana programs; it does not include state laws allowing the medical use of low-THC products in certain situations.

 

While marijuana use remains illegal at the federal level, 27 states and the District of Columbia have made medical use legal.

This page explores comprehensive medical marijuana laws for patients, including the diseases and symptoms that qualify a patient to use medical marijuana, where medical marijuana can be used, whether non-residents can use medical marijuana, and the possession limits for patients. This dataset includes states with comprehensive medical marijuana programs; it does not include state laws allowing the medical use of low-THC products in certain situations.

 

There are now 28 jurisdictions that allow patients to use medical marijuana. In addition, 24 states and the District of Columbia have authorized the operation of dispensaries that give citizens access to medical marijuana products. In those jurisdictions, various state departments are often responsible for developing and implementing the regulations for dispensaries. The regulations focusing on registration and licensing, the number of dispensaries allowed, their location, and operation are examined on this page.

 

In recent years, 27 states and the District of Columbia have legalized medical marijuana. All 28 jurisdictions authorize qualifying patients to appoint a caregiver or caregivers who can help patients acquire, transport or cultivate medical marijuana. Caregivers provide ailing patients with varying degrees of assistance based upon state statutory and regulatory limitations. This dataset analyzes state guidelines for medical marijuana caregivers, including caregiver qualifications and permissible caregiver activities.

 

Unintentional drug overdose is a leading cause of preventable death in the United States. Overdose bystanders may not call for medical assistance for fear of being arrested for drug-related crimes. In response, some states have enacted "Good Samaritan" laws that create immunities or other legal protections for people who call for help in the event of an overdose. Some states have passed comprehensive Good Samaritan overdose prevention laws that provide broad protection.

 

This preliminary dataset examines the laws and policies on medication assisted treatment (MAT) for opioid use disorder at state correctional facilities. The U.S. Food & Drug Administration (FDA) has approved three drugs for the treatment of opioid use disorder: buprenorphine, methadone, and naltrexone. Currently, Rhode Island is the only state that offers all three FDA-approved medications for MAT to all state inmates.  Some states provide all three medications at some of their correctional facilities.

 

Pages